FIELD: medicine.
SUBSTANCE: invention refers to veterinary obstetrics, namely prevention and therapy of mammal dysfunction in female farm animals. The method for prevention of mastitis in cows consists in the single intracisternal introduction of Orbenine DC, the intramuscular introduction of 5.0% emicydine 75 mg per 100 kg of live weight once a day for 7 days 2-3 weeks before calving.
EFFECT: invention provides elimination of clinical mastitis and reduced risk of subclinical mastitis that provides higher biosafety of milk production technology, preserved milk yield in cows, reduced somatic cell count in milk, higher milk quality, reduced treatment expense in animals suffering a mammal pathology.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF SUBCLINICAL AND CLINICAL MASTITIS IN COWS | 2019 |
|
RU2709821C1 |
| METHOD FOR SUBCLINICAL MASTITIS PREVENTION FOR COWS | 2016 |
|
RU2615396C1 |
| METHOD FOR PREVENTION OF SUBCLINICAL AND CLINICAL MASTITIS IN COWS | 2016 |
|
RU2605623C1 |
| METHOD FOR PREVENTION OF SUBCLINICAL AND CHRONIC MASTITIS IN COWS | 2019 |
|
RU2716988C1 |
| METHOD FOR TREATMENT OF MASTITIS IN COWS DURING THE DRY PERIOD | 2021 |
|
RU2779877C1 |
| METHOD OF PROPHYLAXIS OF MASTITIS IN HIGH-PRODUCING COWS | 2016 |
|
RU2668535C2 |
| METHOD OF TREATING MASTITIS IN NON-LACTATING COWS | 2012 |
|
RU2491921C1 |
| PREPARATION FOR TREATMENT AND PREVENTION OF MASTITIS AT COWS IN DRY PERIOD | 2007 |
|
RU2350332C1 |
| METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN COWS | 2016 |
|
RU2612009C1 |
| PREPARATION FOR TREATMENT AND PROPHYLAXIS OF MASTITIS IN COWS AT ONSET OF LACTATION PERIOD AND IN DRY COWS | 2004 |
|
RU2272627C1 |
